KPV
10mg per vial
Anti-inflammatory tripeptide derived from alpha-MSH (α-MSH 11-13). Studied for inhibition of NF-κB signalling in gut and immune research models.
≥99.00% HPLC
$6.50 / mg
Out of stock
Verified purity
For research use only. Not for human consumption. By purchasing this product, you confirm it will be used solely for legitimate research purposes.
Embedded on every product page
Calculate your dose.
Prefilled from the research protocol for the selected product. Pick a chip or type a custom dose.
KPV
Vial size
10 mg
BAC water
Dose
5.00
mg/mL concentration
5.0
units per dose
40
doses per vial
Research protocol default: 250mcg, 2mL BAC water
For research reference only. Not medical advice.
Anti-inflammatory tripeptide derived from alpha-MSH (α-MSH 11-13). Studied for inhibition of NF-κB signalling in gut and immune research models.
KPV (Lysine-Proline-Valine) is a tripeptide fragment of alpha-melanocyte-stimulating hormone (α-MSH 11-13). Independent literature characterises KPV as a PepT1-mediated cellular signalling research tool. Once internalised, KPV is associated in published preclinical work with downregulation of NF-κB nuclear translocation, attenuated TNF-α, IL-1β, and IL-6 secretion under inflammatory challenge, and reduced disease activity scores in chemically induced colitis models. The compound has been investigated across oral, topical, transdermal, and rectal delivery routes in research animals. For research use only. Not for human consumption.
